| 1 | HIV-1 Vif, APOBEC, and Intrinsic Immunity (10.1186/1742-4690-5-51) | Abstract References ORCID License | 244.25 | 276 |
| 2 | Integrase and integration: biochemical activities of HIV-1 i… (10.1186/1742-4690-5-114) | Abstract References ORCID License | 225.53 | 179 |
| 3 | The control of viral infection by tripartite motif proteins… (10.1186/1742-4690-4-40) | Abstract References ORCID License | 225.04 | 177 |
| 4 | HIV-1 Nef: at the crossroads (10.1186/1742-4690-5-84) | Abstract References ORCID License | 217.03 | 147 |
| 5 | Expression of infectious murine leukemia viruses by RAW264.7… (10.1186/1742-4690-5-1) | Abstract References ORCID License | 215.84 | 143 |
| 6 | Common principles and intermediates of viral protein-mediate… (10.1186/1742-4690-5-111) | Abstract References ORCID License | 215.84 | 143 |
| 7 | Host factors influencing susceptibility to HIV infection and… (10.1186/1742-4690-4-52) | Abstract References ORCID License | 200.00 | 99 |
| 8 | Compartmentalization of the gut viral reservoir in HIV-1 inf… (10.1186/1742-4690-4-87) | Abstract References ORCID License | 198.68 | 96 |
| 9 | MicroRNA miR-146a and further oncogenesis-related cellular m… (10.1186/1742-4690-5-100) | Abstract References ORCID License | 195.90 | 90 |
| 10 | Socioeconomic status (SES) as a determinant of adherence to… (10.1186/1742-4690-5-13) | Abstract References ORCID License | 192.43 | 83 |
| 11 | Identifying HIV-1 dual infections (10.1186/1742-4690-4-67) | Abstract References ORCID License | 191.91 | 82 |
| 12 | Classification and characterization of human endogenous retr… (10.1186/s12977-015-0232-y) | Abstract ORCID License | 184.57 | 288 |
| 13 | Host proteins interacting with the Moloney murine leukemia v… (10.1186/1742-4690-5-48) | Abstract References ORCID License | 183.25 | 67 |
| 14 | In-Silico docking of HIV-1 integrase inhibitors reveals a no… (10.1186/1742-4690-4-21) | Abstract References ORCID License | 177.09 | 58 |
| 15 | Pathogenicity and immunogenicity of attenuated, nef-deleted… (10.1186/1742-4690-4-66) | Abstract References ORCID License | 177.09 | 58 |
| 16 | Mechanisms of HIV non-progression; robust and sustained CD4+… (10.1186/1742-4690-5-112) | Abstract References ORCID License | 176.34 | 57 |
| 17 | Turning up the volume on mutational pressure: Is more of a g… (10.1186/1742-4690-5-26) | Abstract References ORCID License | 176.34 | 57 |
| 18 | Rapid inflammasome activation in microglia contributes to br… (10.1186/1742-4690-11-35) | Abstract ORCID License | 175.83 | 220 |
| 19 | Rapid spread of mouse mammary tumor virus in cultured human… (10.1186/1742-4690-4-73) | Abstract References ORCID License | 175.59 | 56 |
| 20 | Optimal design and validation of antiviral siRNA for targeti… (10.1186/1742-4690-4-80) | Abstract References ORCID License | 167.21 | 46 |
| 21 | Apoptosis resistance in HIV-1 persistently-infected cells is… (10.1186/1742-4690-5-19) | Abstract References ORCID License | 167.21 | 46 |
| 22 | APOBEC3G encapsidation into HIV-1 virions: which RNA is it? (10.1186/1742-4690-5-55) | Abstract References ORCID License | 166.28 | 45 |
| 23 | Sequential emergence and clinical implications of viral muta… (10.1186/1742-4690-4-25) | Abstract References ORCID License | 165.32 | 44 |
| 24 | The HIV RNA setpoint theory revisited (10.1186/1742-4690-4-65) | Abstract References ORCID License | 165.32 | 44 |
| 25 | Biphasic decay kinetics suggest progressive slowing in turno… (10.1186/1742-4690-5-107) | Abstract References ORCID License | 165.32 | 44 |
| 26 | Cofilin activation in peripheral CD4 T cells of HIV-1 infect… (10.1186/1742-4690-5-95) | Abstract References ORCID License | 163.35 | 42 |
| 27 | Differential binding of neutralizing and non-neutralizing an… (10.1186/1742-4690-11-41) | Abstract ORCID License | 162.55 | 146 |
| 28 | Early steps of retrovirus replicative cycle (10.1186/1742-4690-1-9) | Abstract ORCID License | 161.65 | 142 |
| 29 | — (10.1186/1742-4690-4-7) | Abstract References ORCID License | 161.28 | 40 |
| 30 | The carbohydrate at asparagine 386 on HIV-1 gp120 is not ess… (10.1186/1742-4690-5-10) | Abstract References ORCID License | 161.28 | 40 |
| 31 | The incidence of multidrug and full class resistance in HIV-… (10.1186/1742-4690-5-12) | Abstract References ORCID License | 156.82 | 36 |
| 32 | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antib… (10.1186/1742-4690-11-15) | Abstract ORCID License | 155.39 | 117 |
| 33 | Human immunodeficiency virus integrase inhibitors efficientl… (10.1186/1742-4690-4-79) | Abstract References ORCID License | 154.41 | 34 |
| 34 | A new genotype of bovine leukemia virus in South America ide… (10.1186/s12977-016-0239-z) | Abstract ORCID License | 149.34 | 97 |
| 35 | H-index, mentoring-index, highly-cited and highly-accessed:… (10.1186/1742-4690-5-106) | Abstract References ORCID License | 149.14 | 30 |
| 36 | New insights into the heterogeneity of Th17 subsets contribu… (10.1186/s12977-016-0293-6) | Abstract ORCID License | 148.67 | 95 |
| 37 | Mortality associated with HIV-1, HIV-2, and HTLV-I single an… (10.1186/1742-4690-4-85) | Abstract References ORCID License | 147.71 | 29 |
| 38 | A formylpeptide receptor, FPRL1, acts as an efficient corece… (10.1186/1742-4690-5-52) | Abstract References ORCID License | 147.71 | 29 |
| 39 | HIV-1 gene expression: lessons from provirus and non-integra… (10.1186/1742-4690-1-13) | Abstract ORCID License | 146.57 | 89 |
| 40 | A novel HIV-1-encoded microRNA enhances its viral replicatio… (10.1186/1742-4690-11-23) | Abstract ORCID License | 145.84 | 87 |
| 41 | microRNAs in viral oncogenesis (10.1186/1742-4690-4-82) | Abstract References ORCID License | 144.72 | 27 |
| 42 | New and old complex recombinant HIV-1 strains among patients… (10.1186/1742-4690-5-69) | Abstract References ORCID License | 144.72 | 27 |
| 43 | Latent HIV-1 is activated by exosomes from cells infected wi… (10.1186/s12977-015-0216-y) | Abstract ORCID License | 143.54 | 81 |
| 44 | Persistence of attenuated HIV-1 rev alleles in an epidemiolo… (10.1186/1742-4690-4-43) | Abstract References ORCID License | 143.14 | 26 |
| 45 | Human T Lymphotropic Virus Type 1 protein Tax reduces histon… (10.1186/1742-4690-5-9) | Abstract References ORCID License | 143.14 | 26 |
| 46 | HIV-1 capsid uncoating initiates after the first strand tran… (10.1186/s12977-016-0292-7) | Abstract ORCID License | 143.14 | 80 |
| 47 | Retrotransposons shape species-specific embryonic stem cell… (10.1186/s12977-015-0173-5) | Abstract ORCID License | 142.73 | 79 |
| 48 | Impact factor, H index, peer comparisons, and Retrovirology:… (10.1186/1742-4690-4-42) | Abstract References ORCID License | 141.50 | 25 |
| 49 | Design of a trans protease lentiviral packaging system that… (10.1186/1742-4690-4-96) | Abstract References ORCID License | 141.50 | 25 |
| 50 | Caspase-3-mediated cleavage of p65/RelA results in a carboxy… (10.1186/1742-4690-5-109) | Abstract References ORCID License | 141.50 | 25 |